כירורגיה - האיגוד הישראלי לרפואה דחופה

כירורגיה - האיגוד הישראלי לרפואה דחופה

By כירורגיה – האיגוד הישראלי לרפואה דחופהMedicineHealth & Fitness
Download on the App Store

כירורגיה - האיגוד הישראלי לרפואה דחופה episodes

  • PODCAST: When you go your way, and I Go Mine – Surgery or Antibiotics for Acute Appendicitis.

    Date: June 12, 2026

    Guest Skeptic: Mr. Ross Fisher. Ross is a paediatric surgeon, presentation guru (P-Cubed), and long-time friend of the SGEM.

    Reference: Talan et al. Nonoperative Treatment of Appendicitis and Implications for Emergency Department Management: A Narrative Review. Ann Emerg Med. June 2026

    Case: A 29-year-old healthy man presents to the emergency department (ED) with 18 hours of abdominal pain that began around the umbilicus and migrated to the right lower quadrant. He has anorexia, nausea, a temperature of 38.1°C, and focal right lower quadrant (RLQ) tenderness without diffuse peritonitis. The white blood cell (WBC) count is 13,500/µL. CT abdomen/pelvis shows an 8-mm inflamed appendix with periappendiceal fat stranding but no abscess, phlegmon, perforation, mass, or appendicolith. He is hemodynamically stable, not immunocompromised, has no history of inflammatory bowel disease (IBD), can return to the ED if worse, and asks whether he really needs surgery tonight.

    Background: Appendicitis is one of those diagnoses we don’t want to miss. It’s common, it can be sneaky, and the classic textbook presentation only shows up around half the time. That means labs and scores can help, but they often can’t rule out appendicitis. In 2026, imaging (especially CT scans) is still doing much of the heavy lifting.

    For more than a century, appendicitis was taught as a surgical emergency: diagnose it, call surgery, and remove the appendix before it ruptures. This new narrative review challenges that mental model. It argues that modern imaging can identify uncomplicated appendicitis, that perforated and nonperforated appendicitis may be biologically different entities, and that short delays to surgery in uncomplicated disease do not appear to increase perforation risk. This new narrative review notes that the American College of Surgeons (ACS) has endorsed antibiotics as a safe alternative for selected patients while continuing to endorse appendectomy.

    The SGEM has followed this topic for years, and our interpretation of the literature has evolved as the evidence has changed (see list of other SGEM episodes at the end of this blog post). In 2015, the SGEM emphasized diagnostic uncertainty and concern that failed antibiotics could increase morbidity; in 2017, the pediatric conclusion was that NOTA was “not ready for prime time.” By 2019, we were more open to antibiotics in selected patients, using shared decision-making and acknowledging that nonoperative care may be better than we thought, though it may (or may not) come with a small absolute increase in complications.

    So, the question is no longer whether to cut or not to cut. The ED question is: who is safe for an antibiotic-first pathway, who needs the surgeon now, and who can reliably come back if things go sideways? This is a classic preference-sensitive decision: surgery is highly definitive, while antibiotics may reduce pain, disability, and time away from school or work, but with a meaningful recurrence/appendectomy risk. This review by Talan et al explicitly places emergency physicians in the shared decision-making role for selected uncomplicated appendicitis patients.

    Clinical Question: In ED patients with imaging-confirmed acute uncomplicated appendicitis, can initial nonoperative management with antibiotics and observation, with appendectomy reserved for worsening, nonresponse, or recurrence, be considered a safe and effective alternative to urgent appendectomy?

    This matters because appendicitis sits right at the intersection of emergency medicine, surgery, radiology, antibiotics, patient values, and system capacity. Some patients want the most definitive treatment. Others want to avoid surgery if it’s safe to do so. Our job is not to sell one option. Our job in the emergency department is to explain the trade-offs.

    Reference: Talan et al. Nonoperative Treatment of Appendicitis and Implications for Emergency Department Management: A Narrative Review. Ann Emerg Med. June 2026

    • Population: Adults and children with clinically suspected, localized, imaging-confirmed acute, uncomplicated appendicitis. The included trials enrolled children as young as 5 years and adults older than 80 years.
      • Exclusions: The major exclusions were diffuse peritonitis, severe systemic illness/sepsis, pregnancy, immunocompromise, renal failure, inflammatory bowel disease (IBD), prior antibiotic-treated appendicitis, and imaging evidence of major abscess, phlegmon, perforation, mass, or tumour. Some trials also excluded appendicolith, abnormal WBC thresholds, prolonged pain duration, or older age.
      • Intervention: Nonoperative treatment: initial antibiotics plus observation, with appendectomy if the patient worsened, failed to improve, or later recurred. Antibiotic regimens varied but generally used parenteral antibiotics followed by oral antibiotics to complete a total therapy of 7–10 days.
      • Comparison: Urgent appendectomy with perioperative antibiotics, usually laparoscopic in the more recent trials.
      • Outcome
        • Primary Outcome: There was no single primary outcome in the review. Across the major trials, the most important outcomes were 1-year appendectomy/treatment failure rates for antibiotic-first care, and in CODA, 30-day EQ-5D health-status noninferiority.
        • Secondary Outcomes: Complications/serious adverse events, pain resolution or pain medication use, disability days, recurrence, ED return visits, feasibility of ED discharge/outpatient treatment, cancer detection, cost-effectiveness, and appendicolith subgroup outcomes
        • Type of Study: Narrative review of the major comparative trials, not a true systematic review or meta-analysis.
        • Authors’ Conclusions: “Nonoperative treatment of uncomplicated appendicitis will be increasingly considered as experience and confidence grows among physicians and as awareness grows among patients in this new treatment option. Emergency physicians are being asked about nonoperative treatment of uncomplicated appendicitis and have an important role now to inform patients of their treatment options and expected associated outcomes, and an emerging role in expanding access to safe and cost-effective care for patients with appendicitis, including those who can be managed by nonoperative treatment of uncomplicated appendicitis as outpatients.”

          Quality Checklist for Systematic Reviews: (Yes/No/Unsure)

          1. Was the clinical question sensible and answerable? Yes
          2. Was the search for studies detailed and exhaustive? No
          3. Were the primary studies of high methodological quality? Unsure
          4. Were the assessments of studies reproducible? No
          5. Were the outcomes clinically relevant? Yes
          6. Was there low statistical heterogeneity for the primary outcomes? N/A
          7. Was the treatment effect large enough and precise enough to be clinically significant? Unsure
          8. Who funded the review? The authors stated that no funding was received for this work.
          9. Did the authors declare any conflicts of interest? The authors reported no conflicts of interest.
          10. Results: The review focused on four major comparative trials: APPAC, CODA, MPSC, and APPY. Together, they included more than 2,000 adults and more than 2,000 children. The review did not provide a pooled table of sex, race, baseline pain duration, comorbidities, or socioeconomic demographics.

            Key Result: In selected patients with uncomplicated appendicitis, antibiotics initially worked in about 90% and reduced pain/disability, but roughly one-third underwent appendectomy within 1 year, with higher appendectomy rates among patients with appendicolith.
            • Primary Outcome:
              • APPAC reported a 1-year appendectomy rate of about 27% in adults treated with antibiotics.
              • CODA found antibiotics noninferior to appendectomy for 30-day EQ-5D health status, but the 1-year appendectomy rate was 36% without appendicolith and 52% with appendicolith.
              • MPSC reported a 1-year appendectomy rate of about 33% in children
              • APPY reported about 34% treatment failure/appendectomy in the antibiotic group. The table on page 3 of the review summarizes these trial-specific results.
              • Secondary Outcomes: These generally favoured antibiotics for short-term recovery, but not always for adverse events.
                • APPAC reported fewer 1-year complications with antibiotics than surgery, 2.8% vs 20.5%, with faster pain resolution and fewer disability days.
                • CODA reported similar serious adverse event rates, 3% vs 3%, and fewer disability days with antibiotics.
                • MPSC reported similar complicated appendicitis rates, 3.6% vs 3.3%, and fewer disability days with antibiotics.
                • APPY reported no serious adverse events in either group, but more mild-to-moderate adverse events with antibiotics, largely GI distress; antibiotics reduced post-discharge pain medication use and disability days.
                • The ED discharge data came mainly from CODA. In a CODA sub-analysis, 335 of 726 antibiotic-treated adults, 46%, were discharged from the ED after longer-acting parenteral antibiotics, observation, oral tolerance, stable status, and pain control. Serious adverse events over 7 days were uncommon: 0.9 per 100 outpatients vs 1.3 per 100 inpatients. ED discharge was associated with fewer appendectomies and about one day less disability, without a significant increase in first-week ED return visits.

                  Summary of the Four RCTs:

                  1. Narrative Review: This was not a systematic review, and that matters. No PRISMA diagram, no duplicate screening, no formal risk-of-bias assessment, and no pooled estimate. That does not make it useless, and we should not judge it against a formal SRMA. It just means we should treat it for what it is, an expert narrative synthesis, not the final word.

                  Open Label

                  2. Open-Label: The included RCTs were not masked and vulnerable to performance, detection, and preference bias. You really can’t blind antibiotics vs surgery. But when outcomes include pain, disability, and the decision to operate, lack of blinding can push things around. Some failures may have been true clinical deterioration. Others may have been surgeon, patient, or system discomfort with waiting.

                  3. Uncomplicated Appendicitis: ED clinicians must exclude abscess, phlegmon, perforation, tumour, diffuse peritonitis, pregnancy, immunocompromise, and other higher-risk conditions. Yet appendicitis diagnosis itself is imperfect: classic symptoms occur in only about half of patients, labs and clinical prediction rules are insufficient to rule in or rule out disease, ultrasound is operator-dependent, and CT can still produce false positives and negative appendectomies. This means the evidence applies best to carefully selected, stable, imaging-confirmed uncomplicated cases, not to all RLQ pain or all appendicitis.

                  Heterogeneity

                  4. Heterogeneity: The RCTs differed by age group, randomization method, inclusion of appendicolith, antibiotic regimen, inpatient versus outpatient management, thresholds for surgery, primary outcome definitions, and noninferiority margins. A one-year appendectomy rate is not the same as patient-important success if a patient’s goal is avoiding an operation today, reducing pain, minimizing time off work, or avoiding recurrence of anxiety. Without a formal meta-analysis, there is no pooled I², no forest plot, and no systematic exploration of heterogeneity.

                  5. Rare & Long-Term Outcomes: These outcomes remain uncertain. Missed appendiceal cancer is uncommon, but the review reports cancer in 5 of 1,033 CODA-qualifying antibiotic-treated adults at 2 years, with a median diagnosis at 3 months and all stage 1. That is reassuring but not definitive for older adults or those with atypical imaging. Pediatric outpatient data remain sparse, and cost-effectiveness depends heavily on the health system, discharge model, return visits, recurrent symptoms, and whether recurrences are treated with antibiotics or surgery. The review is promising for ED pathways, but the evidence is not equally mature for children, patients with appendicolith, older adults, rural sites without surgical backup, or patients with unreliable follow-up.

                  Compare the Authors’ Conclusion Compared with the SGEM Conclusion: The authors seem more optimistic about an expanded ED role. They argue that nonoperative treatment is a safe alternative for selected uncomplicated appendicitis patients, that ED discharge/outpatient care is feasible in many adults, and that emergency physicians should be prepared to initiate shared decision-making and outpatient pathways.

                  We are more cautious due to the strength of the evidence, diagnostic uncertainty, patient selection, the possibility of increased perforation/complications with failed nonoperative care, and the importance of shared decision-making (SDM).

                  SGEM Bottom Line: Antibiotics-first is a reasonable option for carefully selected stable patients with CT-confirmed uncomplicated appendicitis. It is not meant for everyone. Appendectomy is still the definitive treatment, and appendicoliths are a big red flag. It should be shared decision-making, not shared wishful thinking.

                  Case Resolution: The patient’s CT shows uncomplicated appendicitis without appendicolith. Surgery is consulted. After discussing appendectomy versus antibiotics, he says avoiding surgery today is very important because he has no paid sick leave, but he is comfortable returning if getting worse. He receives intravenous (IV) ceftriaxone plus metronidazole, analgesia, and antiemetics. After several hours, he is afebrile, pain is improved, he tolerates oral intake, and he remains hemodynamically stable. He is discharged with oral antibiotics to complete a 7- to 10-day total course, written instructions to return immediately if worse, and follow-up within 24 to 48 hours.

                  Clinical Application: This review should not make ED clinicians offer antibiotics to every patient with appendicitis. It should prompt EDs to create local pathways with surgery, radiology, pharmacy, and follow-up systems. Candidates should have localized uncomplicated appendicitis, no diffuse peritonitis, no abscess/phlegmon/perforation/tumour, no severe sepsis, no pregnancy, no major immunocompromise, no inflammatory bowel disease, and ideally no appendicolith unless the higher failure risk is explicitly discussed. Outpatient management should be reserved for patients who improve, tolerate oral intake, have controlled pain, can access antibiotics, and can reliably return.

                  What Do I Tell the Patient? You have appendicitis, but the CT scan suggests it is the uncomplicated kind. There are two reasonable options. Surgery is the most definitive option. It removes the appendix, so this problem is very unlikely to come back, but it means an operation, anesthesia, incisions, and recovery time. Antibiotics may let you avoid surgery today. In the large studies, most people improved at first, and about 2 out of 3 avoided surgery for at least a year. The trade-off is that about one out of three still needs surgery within a year, and the risk is higher if there is a stone in the appendix. There is not one right answer for everyone. Let’s talk about what matters most to you, and you can decide with the surgery team.

                  Keener Kontest: Last week’s winner was our friend, Dr. Steven Stelts from New Zealand. He knew the 2024 international consensus report defines diabetic ketoacidosis (DKA) by the presence of all three of these features:

                  • Diabetes or Hyperglycaemia – Blood glucose ≥200 mg/dL (11.1 mmol/L) or a prior history of diabetes
                  • Ketosis – Beta-hydroxybutyrate ≥3.0 mmol/L or urine ketones ≥2+
                  • Metabolic Acidosis – Venous/arterial pH <7.3 and/or bicarbonate <18 mmol/L
                  • Listen to the SGEM podcast for this week’s question. If you know the answer, then send an email to [email protected] with “keener” in the subject line. The first correct answer will receive a shout-out.

                    Other SGEM Episodes:

                    • SGEM #115: Complicated-Non-operative Treatment of Appendicitis (NOTA)
                    • SGEM #180: The First Cut is the Deepest- N.O.T. for Paediatric Appendicitis
                    • SGEM #256: Doctor Doctor Give Me the News, I Gotta Bad Case of RLQ Pain- Should I have an Appendectomy?
                    • SGEM #345: Checking In, Checking Out for Non-Operative Treatment of Appendicitis (APPAC II RCT)
                    • SGEM #384: Take Me Out Tonight, I Don’t Want to Perforate My Appendix Alright
                    • SGEM#476: Cuts like a Knife or Antibiotics for Pediatric Appendicitis
                    • The post PODCAST: When you go your way, and I Go Mine – Surgery or Antibiotics for Acute Appendicitis. first appeared on האיגוד הישראלי לרפואה דחופה.

                      41 min
                    • PODCAST: Prehospital Blood Transfusion
                      What is prehospital blood transfusion
                      • Administration of blood products in the field prior to hospital arrival

                      • Aimed at patients in hemorrhagic shock

                        Why this matters
                        • Traditional US prehospital resuscitation relied on crystalloid

                        • ED and trauma care now prioritize early blood

                        • Hemorrhage occurs before hospital arrival

                        • Delays to definitive hemorrhage control are common

                        • Earlier blood may improve survival

                          Supporting rationale
                          • ATLS and trauma paradigms emphasize blood over fluid

                          • National organizations support prehospital blood when feasible

                          • EMS already manages high risk, time sensitive interventions

                            Evidence overview
                            • Data are mixed and evolving

                              • COMBAT: no benefit

                              • PAMPer: mortality benefit

                              • RePHILL: no clear benefit

                              • Signal toward benefit when transport time exceeds ~20 minutes

                              • Urban systems still experience long delays due to traffic and geography

                              • LA County median time to in hospital transfusion ~35 minutes

                                LA County program
                                • ~2 years of planning before launch

                                • Pilot began April 1

                                • Partnerships:

                                  • LA County Fire

                                  • Compton Fire

                                  • Local trauma centers

                                  • San Diego Blood Bank

                                  • 14 units of blood circulating in the field

                                  • Blood rotated back 14 days before expiration

                                  • Ultimately used at Harbor UCLA

                                  • Continuous temperature and safety monitoring

                                    Indications used in LA County
                                    • Focused rollout

                                    • Trauma related hemorrhagic shock

                                    • Postpartum hemorrhage

                                      Physiologic criteria:

                                      • SBP < 70

                                      • Or HR > 110 with SBP < 90

                                      • Shock index ≥ 1.2

                                      • Witnessed traumatic cardiac arrest

                                        Products:

                                        • One unit whole blood preferred

                                        • Two units PRBCs if whole blood unavailable

                                          Early experience
                                          • ~28 patients transfused at time of discussion

                                          • Evaluating:

                                            • Indications

                                            • Protocol adherence

                                            • Time to transfusion

                                            • Early outcomes

                                            • Too early for outcome conclusions

                                              California collaboration
                                              • Multiple active programs:

                                                • Riverside (Corona Fire)

                                                • LA County

                                                • Ventura County

                                                • Additional programs planned:

                                                  • Sacramento

                                                  • San Bernardino

                                                  • Programs meet monthly as CalDROP

                                                  • Focus on shared learning and operational optimization

                                                    Barriers and concerns
                                                    • Trauma surgeon concerns about blood supply

                                                    • Need for system wide buy in

                                                    • Community engagement

                                                    • Patients who may decline transfusion

                                                    • Women of childbearing age and alloimmunization risk

                                                    • Risk of HDFN is extremely low

                                                    • Clear communication with receiving hospitals is essential

                                                      Future direction
                                                      • Rapid national expansion expected

                                                      • Greatest benefit likely where transport delays exist

                                                      • Prehospital Blood Transfusion Coalition active nationally

                                                      • Major unresolved issue: reimbursement

                                                      • Currently funded largely by fire departments

                                                      • Sustainability depends on policy and payment reform

                                                        Take-Home Points
                                                        • Hemorrhagic shock is best treated with blood, not crystalloid

                                                        • Prehospital transfusion may benefit patients with prolonged transport times

                                                        • Implementation requires strong partnerships with blood banks and trauma centers

                                                        • Early data are promising, but patient selection remains critical

                                                        • National collaboration is key to sustainability and future growth

                                                          The post PODCAST: Prehospital Blood Transfusion first appeared on האיגוד הישראלי לרפואה דחופה.

                                                          14 min
                                                        • PODCAST: Acute Mesenteric Ischemia

                                                          In this episode, Sam Ashoo, MD and T.R. Eckler, MD discuss the December 2024 Emergency Medicine Practice article, Diagnosis and Management of Acute Mesenteric Ischemia in the Emergency Department

                                                          • Introduction to Acute Mesenteric Ischemia
                                                          • Statistics on prevalence and mortality
                                                          • Pathophysiology and Etiology
                                                            • Mesenteric artery embolism
                                                            • Mesenteric artery thrombosis
                                                            • Mesenteric venous thrombosis
                                                            • Non-occlusive mesenteric ischemia
                                                            • Diagnosis
                                                            • Management and Treatment
                                                            • Special Populations
                                                              • Pediatric patients
                                                              • Pregnant patients
                                                              • Elderly patients
                                                              • Emergency Medicine Residents, get your free subscription by writing [email protected]

                                                                Sam Ashoo, MD

                                                                Sam Ashoo, MD, FACEP,  is board certified in emergency medicine and clinical informatics. He serves as EB Medicine’s editor-in-chief of interactive clinical pathways and FOAMEd blog, and host of EB Medicine’s EMplify podcast. Follow him below for more…

                                                                The post PODCAST: Acute Mesenteric Ischemia first appeared on האיגוד הישראלי לרפואה דחופה.

                                                                41 min
                                                              • PODCAST: SPEED, GIVE ME WHAT I NEED – TO DIAGNOSE ACUTE AORTIC DISSECTIONS

                                                                Reference: Gibbons et al. The sonographic protocol for the emergent evaluation of aortic dissections (SPEED protocol): A multicenter, prospective, observational study. AEM February 2024.

                                                                Date: February 28, 2024

                                                                Guest Skeptic: Dr. Neil Dasgupta is an emergency medicine physician and ED intensivist from Long Island, NY.  He is the Vice Chair of the Emergency Department at Nassau University Medical Center in East Meadow, NY, the safety net hospital for Nassau County.

                                                                Case: A 59-year-old man walks into your community emergency department (ED) complaining of chest pain. It is described as a ripping sensation that radiates to his back. His vital signs are all normal and the ECG done at triage does not show an occlusive myocardial infarction. The chest x-ray is unremarkable, and his troponin is not elevated. You suspect an acute aortic dissection (AoD). However, your CT scanner is offline for two hours of scheduled maintenance. He will need to be transferred to the tertiary care center which is 35 minutes away by ground EMS if it is a dissection. Your Spidey senses are tingling, and you don’t want to wait for the CT scanner to be back online to make the diagnosis. Arrangements are made for him to be transferred stat to the tertiary hospital while he is still stable. You wonder if a quick POCUS examination looking for three sonographic findings while waiting for the paramedics could help determine the likelihood of this being an AoD.

                                                                Background: We recently covered acute aortic syndrome (AAS) on SGEM#430. AAS has been called the lethal triad and includes aortic dissection (AD), intramural hematoma (IMH), and penetrating aortic ulcer [1]. It is a rare but deadly condition that can present in atypical ways leading to delays in diagnosis and an associated increase in mortality.

                                                                This episode is going to focus on acute aortic dissection (AoD) which is classified into two major types according to the Stanford classification system: Type A and Type B. This system is based on the location of the tear and helps guide treatment strategies.

                                                                Type A dissections Involves the ascending aorta and may extend into the descending aorta. It’s more common and more dangerous than Type B, as it can lead to serious complications like rupture into the pericardial space leading to cardiac tamponade, aortic valve insufficiency, or myocardial infarction. Symptoms may include more severe chest pain radiating to the back, loss of consciousness, or symptoms of stroke if the blood supply to the brain is affected. Type A AoDs generally require an emergent trip to the operating room as soon as they are identified to reduce the likelihood of a terrible outcome.

                                                                Type B dissections occur in the descending aorta only, after it has passed the arteries that supply blood to the arms and head. They are less common than Type A and usually less immediately life-threatening, but still serious and potentially fatal if not treated properly. Symptoms can include sudden onset of pain in the back or abdomen, depending on the exact location and extent of the dissection. The pain is often described as tearing or ripping.

                                                                Speed is important in making the diagnosis of an AoD due to the associated increase in mortality with delays [2,3]. We know from last week that clinical decision tools (CDTs) are not ready for prime time. This is consistent with the American College of Emergency Physicians (ACEP) which does not recommend the routine use of clinical decision rules in suspected cases of AoD [4].

                                                                CLINICAL QUESTION: WHAT IS THE DIAGNOSTIC ACCURACY OF THREE SONOGRAPHIC FINDINGS FOR ACUTE AORTIC DISSECTION?

                                                                Reference: Gibbons et al. The sonographic protocol for the emergent evaluation of aortic dissections (SPEED protocol): A multicenter, prospective, observational study. AEM February 2024.

                                                                • Population: A convenience sample of adult patients with clinically suspected Stanford type A or B AoDs before performing a POCUS or CTA from January 2010 to December 2019
                                                                  • Excluded: Those patients unable to consent, those with a preexisting or traumatic AoD, and individuals who did not receive a POCUS evaluation prior to advanced imaging (CTA, MRA, or TEE).
                                                                  • Intervention: POCUS performed by PGY1 to 3 EM residents to identify three sonographic findings consistent with acute aortic dissection. This included (1) the presence of either a pericardial effusion or (2) an intimal flap, or (3) an aortic outflow track (AOFT) diameter greater than 35 mm measured from the inner wall to the inner wall within 20 mm of the aortic annulus during end-diastole.
                                                                  • Comparison: CTA of chest-abdomen-pelvis, MRI/MRA, or cardiology-performed TEE
                                                                  • Outcome:
                                                                    • Primary Outcome: Diagnostic accuracy of identifying a Stanford Type A and B AoDs
                                                                    • Secondary Outcomes: Test characteristics of each of the three individual sonographic findings for diagnosing Stanford type A and B AoDs
                                                                    • Type of Study: Multicenter, prospective, observational, cohort study of a convenience sample of adult patients.
                                                                    • Dr. Ryan Gibbons

                                                                      This is the first SGEMHOP of 2024. I’m pleased to introduce Dr. Ryan Gibbons. He is a proud graduate of the Lewis Katz School of Medicine (LKSOM) at Temple University where he completed his Emergency Medicine (EM) residency, serving as chief resident, followed by an Advanced Emergency Medicine Ultrasonography (AEMUS) fellowship at Temple as well. Currently, Dr. Gibbons is an Associate Professor of EM, AEMUS fellowship director, and the Director of Ultrasound in Undergraduate Medical Education (UME). 

                                                                      Authors’ Conclusions: “The SPEED protocol has an overall sensitivity of 93.2% for AoD.”

                                                                      Quality Checklist for Observational Study:

                                                                      1. Did the study address a clearly focused issue? Yes
                                                                      2. Did the authors use an appropriate method to answer their question? Unsure
                                                                      3. Was the cohort recruited in an acceptable way? No
                                                                      4. Was the exposure accurately measured to minimize bias? Yes
                                                                      5. Was the outcome accurately measured to minimize bias? Yes
                                                                      6. Have the authors identified all-important confounding factors? No
                                                                      7. Was the follow-up of subjects complete enough? Yes
                                                                      8. How precise are the results? Not very precise with a wide 95% CI
                                                                      9. Do you believe the results? Yes
                                                                      10. Can the results be applied to the local population? Unsure
                                                                      11. Do the results of this study fit with other available evidence? No
                                                                      12. Funding of the Study: Investigators received no funding and declared no conflicts of interest
                                                                      13. Results: Over the ten years, 1,314 patients were approached and agreed to be enrolled in the study. The median age was 59 years with 49% being female. There were 21 (1.5%) Stanford type A and 23 (1.8%) Stanford type B dissections diagnosed. Of the 44 (3.3%) cases diagnosed, 41 of them (93.2%) had at least one finding present on POCUS.

                                                                        KEY RESULT: WHILE THE SENSITIVITY OF POCUS FOR AORTIC DISSECTION WAS HIGH, THE 95% CONFIDENCE INTERVAL AROUND THE POINT ESTIMATE WAS VERY WIDE DUE TO THE LOW NUMBER OF CASES.
                                                                        • Primary Outcome: Diagnostic accuracy of identifying a Stanford type A and B AoDs
                                                                          • Secondary Outcomes: Test characteristics of each of the three individual sonographic findings for diagnosing Stanford type A and B AoDs.
                                                                          • Listen to the SGEM podcast to hear Ryan answer our five nerdy questions.

                                                                            1. Convenience Sample: These were not consecutive patients but rather a convenience sample of patients with suspected AoD. How did patients ultimately make it into the study, and what biases could this have introduced into the sample?

                                                                            2. Ultrasonographers: These scans were done by PGY1 – PGY3 emergency medicine residents. They received a four-hour introductory course taught by our emergency ultrasound faculty. In addition, each resident completed a three-week emergency ultrasound rotation during their internship. They did not receive any additional formal training before participating in the study except for the standard bedside teaching throughout their residency. Do you think this can be extrapolated to an attending physician in a non-academic, community or rural setting?

                                                                            3. Lack of Masking: Physicians performing the scan were not masked. They also had access to laboratory results (d-dimer) and plain film imaging. How do you think that could have biased the results?

                                                                            4. Prevalence Higher: Your prevalence of 3.5% was high compared to previously published data [5.6]. This too suggests some selection bias. What other biases could this suggest?

                                                                            5. Prevalence Sill Low: The 3.5% is still a small number even if it is larger than other published data. This small number of cases results in a wide 95% confidence interval around the point estimate for the diagnostic accuracy metrics. What impact do you think this may have had on your results?

                                                                            Comment on Authors’ Conclusion Compared to SGEM Conclusion: We agree with the authors’ conclusions but would have added that there was a wide confidence interval around the reported 93.2% sensitivity.

                                                                            SGEM BOTTOM LINE: AORTIC DISSECTIONS ARE RARE DIAGNOSES, DEADLY DIAGNOSES AND HARD TO DIAGNOSE EVEN WITH POCUS.

                                                                            Case Resolution: The vascular surgeon says to get on the road and don’t wait for the CT scanner to be up and running. Speed is of the essence, and they will be standing by on arrival to assess the patient. The patient arrives alive, and you transfer care to the vascular team. When you get back to the community hospital you find out the CTA shows a Stanford Type B aortic dissection, and the vascular team is discussing the next steps with the patient and their family.

                                                                            Dr. Neil Dasgupta

                                                                            Clinical Application: This is an interesting study but would need to be replicated in other clinical settings to see if it could be a fast and accurate way to diagnose AoD.

                                                                            What Do I Tell the Patient? It looks like the large blood vessel coming off your heart has a tear. This is a serious and potentially deadly condition. We need to get you to the city hospital ASAP. The ambulance is on the way and the vascular surgeons are waiting for you to arrive.

                                                                            Keener Kontest: Last week’s winner was David Bowden. He knew St. John’s Wort has some evidence for efficacy in the treatment of mild to moderate depression

                                                                            Listen to the podcast to hear the question for this episode. If you think you know the answer, send an email to [email protected].  The first correct answer will receive a cool skeptical prize.

                                                                            SGEMHOP: Now it is your turn SGEMers. What do you think of this episode on POCUS for diagnosing AoD? Tweet your comments using #SGEMHOP. What questions do you have for Ryan and his team? Ask them on the SGEM blog. The best social media feedback will be published in AEM.

                                                                            REMEMBER TO BE SKEPTICAL OF ANYTHING YOU LEARN, EVEN IF YOU HEARD IT ON THE SKEPTICS’ GUIDE TO EMERGENCY MEDICINE.

                                                                            References:

                                                                            1. Rotella JA, Yeoh M. Taming the zebra: unravelling the barriers to diagnosing aortic dissection. Emerg Med Australas 2018;30:119–21.
                                                                            2. Erbel R, Aboyans V, Boileau C, et al. 2014 ESC guidelines on the di- agnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2873-2926.
                                                                            3. Pape LA, Awais M, Woznicki EM, et al. Presentation, diagnosis, and outcomes of acute aortic dissection: 17-year trends from the International Registry of Acute Aortic Dissection. J Am Coll Cardiol. 2015;66(4):350-358.
                                                                            4. Diercks DB, Promes SB, Schuur JD, Shah K, Valente JH, Cantrill SV. Clinical policy: critical issues in the evaluation and management of adult patients with suspected acute nontraumatic thoracic aortic dissection. Ann Emerg Med. 2015;65:32-42.
                                                                            5. Tsai TT, Nienaber CA, Eagle KA. Acute aortic syndromes. Circulation. 2005;112:3802-3813.
                                                                            6. Fojtik JP, Costantino TG, Dean AJ. The diagnosis of aortic dissection by emergency medicine ultrasound. J Emerg Med. 2007;32(2):191-196.
                                                                            7. The post PODCAST: SPEED, GIVE ME WHAT I NEED – TO DIAGNOSE ACUTE AORTIC DISSECTIONS first appeared on האיגוד הישראלי לרפואה דחופה.

                                                                              35 min

                                                                            About כירורגיה - האיגוד הישראלי לרפואה דחופה

                                                                            From the publisher's feed

                                                                            The Israel Association for Emergency Medicine